Key result
Conservative HOCM treatment linked to ~10-fold higher SCD risk versus invasive therapy.
Why the study?
There is no clear consensus on the long-term effects of conservative versus invasive treatment strategies in patients with hypertrophic obstructive cardiomyopathy.
Does invasive treatment reduce mortality and SCD-related events compared to conservative treatment in patients with HOCM?
Cohort (n=106)
No
Does invasive treatment reduce mortality and SCD-related events compared to conservative treatment in patients with HOCM?
Invasive treatment for HOCM is associated with a lower risk of SCD-related events compared to conservative management, though overall survival is similar and invasive treatment increases the need for pacing.
Answers are grounded in this paper and cite their sources.
May favor invasive HOCM strategies to lower SCD events; leaves open confirmation in randomized trials before practice change.
Background and objective: Treatment for patients with hypertrophic obstructive cardiomyopathy (HOCM) can be either conservative or invasive (alcohol septal ablation (ASA) and myectomy). As there is no clear consensus on the long-term effects of these different strategies, the aim was to compare the long-term outcome in a large tertiary referral university hospital.Methods: We retrospectively included 106 HOCM patients. Twenty-nine (27.4%) patients were treated conservatively, 25 (23.6%) underwent ASA and 52 (49.0%) myectomy. Endpoints were all-cause mortality and sudden cardiac death (SCD)-related events (including SCD, aborted SCD and appropriate ICD shocks). Kaplan–Meier survival analysis and Cox proportional hazard regression models were used.Results: The mean follow-up period was 7.7 ± 4.9 years. Overall, there was no significant difference in survival between the three treatment strategies (p = 0.7). Annual rates of SCD-related events at 5 years and the complete follow-up period were significantly higher (p = 0.034) after conservative treatment (4.9%/year and 2.7%/year, respectively) compared to ASA (0.9%/year, 0.5%/year) and myectomy (1.0%/year, 0.6%/year). Independent predictors of SCD-related events were: conservative treatment (HR 10.66; 1.88–60.55), a known mutation (HR 9.36; 1.43–61.20), left ventricular wall thickness (LVWT) > 30 mm (HR 6.48; 1.05–39.92) and non-sustained VT (HR 16.82; 2.29–123.29). Invasive treatment resulted in a significant higher proportion of patients requiring pacing (p = 0.033).Conclusions: Long-term mortality rates for patients with HOCM are similarly low between treatment groups. However, conservative treatment was associated with SCD-related events, as were known mutations, increased LVWT and non-sustained VT. Invasive treatment was associated with a higher need for implantation of a pacemaker.
No takes yet. Share an insight, caveat, or question.
Hoedemakers et al. (2018) conducted a cohort in hypertrophic obstructive cardiomyopathy (HOCM) (n=106). Conservative treatment vs. Invasive treatment (alcohol septal ablation and myectomy) was evaluated on Sudden cardiac death (SCD)-related events (HR 10.66, 95% CI 1.88-60.55, p=0.034). Conservative treatment in patients with HOCM was associated with a higher risk of SCD-related events compared to invasive treatment.
Synapse has enriched 10 related papers. Consider them for comparative context: